Here are four points:
1. Bank of Montreal Can owned 2.29 percent of EndoChoice worth $4.73 million as of its most recent filing with the SEC.
2. The stock has a 50-day moving average price of $5.00 and a 200-day moving average price of $7.44.
3. EndoChoice has a 12-month low of $3.70 and a 12-month high of $19.69.
4. The company’s market capitalization is $133.4 million.
More articles on GI/endoscopy:
ACA, Medicare, ACOs & more: 5 things to know on gastroenterologist pay
5 most read GI/endoscopy stories: April 11 – April 15
NanoAntibiotics acquires company developing medicines for liver cirrhosis complications: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
